Absci/$ABSI

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX

About Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Ticker

$ABSI
Primary listing

Industry

Biotechnology

Employees

157

ISIN

US00091E1091

Absci Metrics

BasicAdvanced
$343M
-
-$0.92
2.20
-

What the Analysts think about Absci

Analyst ratings (Buy, Hold, Sell) for Absci stock.

Bulls say / Bears say

Absci's AI-driven platform can design antibodies to precisely target an epitope with optimized interface contacts to ensure high potency and affinity, setting itself apart from competitors. (tipranks.com)
Absci has struck multiple pharma deals and achieved key design milestones, validating its technology and likely attracting further partnerships. (tipranks.com)
Absci had approximately $112M in cash and cash equivalents at the end of 4Q24 and raised approximately $40M in equity funding since then, resulting in a pro forma cash balance of $152M. (tipranks.com)
For 4Q24, the company reported revenues of $0.7M, which was below the consensus estimate of $1.8M, and a net loss of $0.25 per share, compared to the consensus estimated net loss of $0.22 per share. (tipranks.com)
Q4 revenues of $0.7M brought FY24 total revenues to $4.5M, below expectations. (tipranks.com)
Absci's net margin excels beyond industry benchmarks, reaching -1610.7%. This signifies efficient cost management and strong financial health. (nasdaq.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.

Absci Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Absci Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ABSI

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs